
Mettler-Toledo International MTD
$ 1 241.27
-1.7%
Annual report 2025
added 02-06-2026
Mettler-Toledo International P/CF Ratio 2011-2026 | MTD
Annual P/CF Ratio Mettler-Toledo International
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 29.7 | 30.9 | 26.6 | 39.5 | 37.5 | 38.5 | 37.7 | 37.8 | 44.8 | 35.1 | 25.1 | 26.6 | 28.3 | 28.3 | 30.8 |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 44.8 | 25.1 | 33.1 |
P/CF Ratio of other stocks in the Diagnostics research industry
| Issuer | P/CF Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Akumin
AKU
|
1.15 | - | -17.87 % | $ 25.9 M | ||
|
Burning Rock Biotech Limited
BNR
|
-40.2 | $ 16.34 | -1.86 % | $ 179 M | ||
|
Centogene N.V.
CNTG
|
26.1 | - | -6.23 % | $ 30.6 M | ||
|
Agilent Technologies
A
|
28.3 | $ 111.53 | -2.92 % | $ 33.9 B | ||
|
Castle Biosciences
CSTL
|
10.9 | $ 23.84 | -3.5 % | $ 662 M | ||
|
Accelerate Diagnostics
AXDX
|
-0.826 | - | -61.36 % | $ 2.46 M | ||
|
Aspira Women's Health
AWH
|
-1.41 | - | -6.19 % | $ 10.5 M | ||
|
Biocept
BIOC
|
-0.447 | - | -13.05 % | $ 7.29 M | ||
|
Chembio Diagnostics
CEMI
|
-0.991 | - | 0.22 % | $ 16.8 M | ||
|
Check-Cap Ltd.
CHEK
|
-0.541 | - | - | $ 9.42 M | ||
|
Co-Diagnostics
CODX
|
-0.201 | $ 1.58 | -3.07 % | $ 2.1 M | ||
|
CareDx, Inc
CDNA
|
23.6 | $ 19.79 | -9.68 % | $ 1.05 B | ||
|
Oxford Immunotec Global PLC
OXFD
|
-47.7 | - | - | $ 562 M | ||
|
DermTech
DMTK
|
-0.551 | - | -11.32 % | $ 2.94 M | ||
|
Enzo Biochem
ENZ
|
-0.00219 | - | -8.98 % | $ 14.8 K | ||
|
Exact Sciences Corporation
EXAS
|
39.7 | - | - | $ 19.8 B | ||
|
Fulgent Genetics
FLGT
|
22.2 | $ 14.8 | -3.27 % | $ 447 M | ||
|
Illumina
ILMN
|
19.6 | $ 122.56 | -3.44 % | $ 19.5 B | ||
|
Global Cord Blood Corporation
CO
|
0.396 | - | - | $ 399 M | ||
|
Fluidigm Corporation
FLDM
|
-17.1 | - | 1.08 % | $ 308 M | ||
|
Genetic Technologies Limited
GENE
|
-1.63 K | - | - | $ 7.1 B | ||
|
Genetron Holdings Limited
GTH
|
-2.94 | - | 0.12 % | $ 80.1 M | ||
|
Charles River Laboratories International
CRL
|
10.4 | $ 165.31 | -0.84 % | $ 8.19 B | ||
|
PRA Health Sciences, Inc.
PRAH
|
21.8 | - | - | $ 10.7 B | ||
|
HTG Molecular Diagnostics
HTGM
|
-0.162 | - | -20.0 % | $ 1.06 M | ||
|
Guardant Health
GH
|
-72.7 | $ 80.34 | -3.34 % | $ 10.1 B | ||
|
Neogen Corporation
NEOG
|
17.5 | $ 9.06 | -3.05 % | $ 1.97 B | ||
|
Lantheus Holdings
LNTH
|
13.1 | $ 81.05 | -2.99 % | $ 5.47 B | ||
|
Heska Corporation
HSKA
|
-38.7 | - | - | $ 1.31 B | ||
|
Koninklijke Philips N.V.
PHG
|
26.5 | $ 25.65 | -5.47 % | $ 20 B | ||
|
Interpace Biosciences
IDXG
|
1.26 | $ 1.96 | 1.5 % | $ 8.67 M | ||
|
Personalis
PSNL
|
-5.62 | $ 5.17 | -6.0 % | $ 306 M | ||
|
Senseonics Holdings
SENS
|
-5.93 | $ 6.72 | -6.41 % | $ 280 M | ||
|
QIAGEN N.V.
QGEN
|
12.6 | - | - | $ 10.6 B | ||
|
Medpace Holdings
MEDP
|
18.2 | $ 413.73 | 0.97 % | $ 11.9 B | ||
|
Biomerica
BMRA
|
-1.87 | $ 2.16 | -1.22 % | $ 4.96 M | ||
|
Trinity Biotech plc
TRIB
|
9.03 | $ 0.6 | -1.75 % | $ 61.9 M | ||
|
Motus GI Holdings
MOTS
|
-0.0884 | - | -34.28 % | $ 263 K | ||
|
ICON Public Limited Company
ICLR
|
12.9 | $ 115.5 | 12.69 % | $ 9.53 B | ||
|
Laboratory Corporation of America Holdings
LH
|
14.6 | $ 253.28 | -2.41 % | $ 21.1 B | ||
|
Twist Bioscience Corporation
TWST
|
-32.8 | $ 57.4 | -2.96 % | $ 3.43 B | ||
|
NeoGenomics
NEO
|
284 | $ 8.45 | -6.32 % | $ 1.08 B | ||
|
Celcuity
CELC
|
-35 | $ 119.85 | -0.18 % | $ 5.6 B | ||
|
National Research Corporation
NRC
|
11.9 | $ 15.97 | -5.17 % | $ 357 M | ||
|
Myriad Genetics
MYGN
|
227 | $ 4.64 | -4.03 % | $ 430 M | ||
|
Natera
NTRA
|
-12.3 | $ 193.57 | -3.3 % | $ 19 B | ||
|
Quest Diagnostics Incorporated
DGX
|
12.4 | $ 187.94 | -3.61 % | $ 20.9 B | ||
|
Exagen
XGN
|
-5.14 | $ 2.66 | -2.56 % | $ 57.3 M | ||
|
Invitae Corporation
NVTA
|
-1.04 | - | - | $ 21.2 M | ||
|
OpGen
OPGN
|
-1.87 | - | -16.95 % | $ 1.54 M |